A detailed history of Exane Derivatives transactions in Johnson Outdoors Inc stock. As of the latest transaction made, Exane Derivatives holds 5 shares of JOUT stock, worth $186. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 1,268 99.61%
Holding current value
$186
Previous $98,000 100.0%
% of portfolio
0.0%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$59.04 - $82.48 $74,567 - $104,172
-1,263 Reduced 99.61%
5 $0
Q1 2022

Apr 22, 2022

SELL
$77.44 - $95.6 $19,902 - $24,569
-257 Reduced 16.85%
1,268 $98,000
Q4 2021

Jan 28, 2022

SELL
$92.82 - $115.87 $46,131 - $57,587
-497 Reduced 24.58%
1,525 $142,000
Q3 2021

Oct 26, 2021

SELL
$105.51 - $122.23 $29,437 - $34,102
-279 Reduced 12.13%
2,022 $213,000
Q2 2021

Jul 28, 2021

SELL
$117.92 - $154.09 $88,204 - $115,259
-748 Reduced 24.53%
2,301 $278,000
Q1 2021

Apr 30, 2021

SELL
$109.0 - $148.5 $139,629 - $190,228
-1,281 Reduced 29.58%
3,049 $435,000
Q4 2020

Jan 27, 2021

BUY
$82.81 - $113.21 $358,567 - $490,199
4,330 New
4,330 $487,000

Others Institutions Holding JOUT

About JOHNSON OUTDOORS INC


  • Ticker JOUT
  • Exchange NASDAQ
  • Sector Consumer Cyclical
  • Industry Leisure
  • Shares Outstandng 8,965,300
  • Market Cap $334M
  • Description
  • Johnson Outdoors Inc. designs, manufactures, and markets seasonal and outdoor recreational products for fishing worldwide. It operates through four segments: Fishing, Camping, Watercraft Recreation, and Diving. The Fishing segment offers electric motors for trolling, marine battery chargers, and shallow water anchors; sonar and GPS equipment for...
More about JOUT
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.